Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020.
Thomas WilliamsSandra JacksonIan G BarrShabana BiJinal BhimanJoanna EllisAnne von GottbergStephen LindstromTeresa PeretSanjiv RughooputhMariana ViegasSiddhivinayak HirveMaria ZambonWenqing Zhangnull nullNdongo DiaNorosoa RazanazatovoAjaeb Dakhilalla M H Al-NabetAbdinasir AbubakarAlmiro TivaneAmal BarakatAmel NaguibAmmar AzizAndrea VicariAnn MoenArunkumar GovindakarnavarAron HallBadarch DarmaaBastien NathalieBelinda HerringBraulia C CaetanoBrett WhittakerElsa BaumeisterEmmanuel NakounéErica GuthrieFrancis InbanathanHarish NairHarry CampbellHerve A KadjoHicham OumzilJean-Michel HeraudJoshua A MottJoyce NamulondoJuliana LeiteKaren NahapetyanLubna Al AriqiMahmoud Hamad Ibraheem GazoMandeep ChadhaMaria PisarevaMarietjie VenterMarilda M SiqueiraMayan LumandasMbayame NiangMona AlbuainiMuhammad SalmanSteve OberstePadmini SrikantiahPatrick TangPaula CoutoPeter SmithPeter Valentine CoylePhilippe DussartPhuong Nam NguyenPilailuk Akkapaiboon OkadaPushpa Ranjan WijesingheReuben SamuelRichard BrownRichard PebodyRodrigo FasceRuna JhaStephen LindstromSue GerberVarsha PotdarXiaomin DongYi Mo DengPublished in: Influenza and other respiratory viruses (2023)
The WHO RSV EQA 2019-2020 showed that laboratories performed at high standards. Updating the composition of RSV molecular EQAs with contemporary strains to ensure representation of circulating strains, and ensuring primer matching with EQA panel viruses, is advantageous in assessing diagnostic competencies of laboratories. Ongoing EQAs are recommended because of continued evolution of mismatches between current circulating strains and existing primer sets.